Viking Therapeutics (VKTX) Misses Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street rallies as Fed's Waller eases rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Citi Starts Viking Therapeutic (VKTX) at Neutral
February 7, 2025 6:52 AM ESTCiti analyst David Lebowitz initiates coverage on Viking Therapeutic (NASDAQ: VKTX) with a Neutral rating and a price target of $38.00.
The analyst comments "The relatively recent emergence of GLP-1s for the treatment of obesity has rapidly established a megamarket opportunity... More
Viking Therapeutic (VKTX) PT Lowered to $95 at Truist Securities
February 6, 2025 12:07 PM ESTTruist Securities analyst Joon Lee lowered the price target on Viking Therapeutic (NASDAQ: VKTX) to $95.00 (from $120.00) while maintaining a Buy rating.
The analyst comments "4Q24 update narrowed timeline for the start of 2x Ph3 studies of SQVK2735 in obesity. Toplines from Ph3... More
